Evidence map›Paper›PMID 37888374›Full record

ArticleGels (Basel, Switzerland)2023

Modulation of Methacrylated Hyaluronic Acid Hydrogels Enables Their Use as 3D Cultured Model.

Ornella Ursini, Maddalena Grieco, Carla Sappino, Agostina Lina Capodilupo, Sara Maria Giannitelli, Emanuele Mauri, Alessio Bucciarelli, Chiara Coricciati, Valeria de Turris, Giuseppe Gigli and 2 more

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Biomimetic Scaffold-Based 3D Models for Decoding Cancer Biology and Advancing Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ornella UrsiniNational Research Council-Institute of Nanotechnology (CNR Nanotec), c/o Edificio Fermi, University Sapienza, Pz.le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0002-4544-3871
Maddalena GriecoNational Research Council-Institute of Nanotechnology (CNR Nanotec), c/o Ecotekne, University of Salento, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0001-5407-4150
Carla SappinoDepartment of Chemistry, Sapienza University Rome, Pz.le A. Moro 5, 00185 Rome, Italy.
Agostina Lina CapodilupoNational Research Council-Institute of Nanotechnology (CNR Nanotec), c/o Ecotekne, University of Salento, Via Monteroni, 73100 Lecce, Italy.
Sara Maria GiannitelliDepartment of Science and Technology for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID 0000-0002-3616-5953
Emanuele MauriDepartment of Engineering, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID 0000-0002-6203-8405
Alessio BucciarelliNational Research Council-Institute of Nanotechnology (CNR Nanotec), c/o Ecotekne, University of Salento, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0001-5719-4617
Chiara CoricciatiNational Research Council-Institute of Nanotechnology (CNR Nanotec), c/o Ecotekne, University of Salento, Via Monteroni, 73100 Lecce, Italy.ORCID 0009-0003-6718-4924
Valeria de TurrisCenter for Life Nano- & Neuro- Science Italian Institute of Technology (IIT), 00161 Rome, Italy.ORCID 0000-0003-0872-185X
Giuseppe GigliNational Research Council-Institute of Nanotechnology (CNR Nanotec), c/o Ecotekne, University of Salento, Via Monteroni, 73100 Lecce, Italy.
Lorenzo MoroniNational Research Council-Institute of Nanotechnology (CNR Nanotec), c/o Ecotekne, University of Salento, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0003-1298-6025
Barbara CorteseNational Research Council-Institute of Nanotechnology (CNR Nanotec), c/o Edificio Fermi, University Sapienza, Pz.le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0001-8667-7255

Funding

Italian Association for Cancer Research IG 2021 - ID. 26328Tecnopolo di Nanotecnologia e Fotonica per la medicina di precisione" (TECNOMED) FISR/MIUR-CNR: delibera CIPE n.3449 del 7-08-2017, CUP: B83B17000010001Tecnopolo per la medicina di precisione (TecnoMed Puglia) Regione Puglia: DGR n.2117 del 21/11/2018 CUP: B84I18000540002
6 · The paper itself

Abstract

Bioengineered hydrogels represent physiologically relevant platforms for cell behaviour studies in the tissue engineering and regenerative medicine fields, as well as in in vitro disease models. Hyaluronic acid (HA) is an ideal platform since it is a natural biocompatible polymer that is widely used to study cellular crosstalk, cell adhesion and cell proliferation, and is one of the major components of the extracellular matrix (ECM). We synthesised chemically modified HA with photo-crosslinkable methacrylated groups (HA-MA) in aqueous solutions and in strictly monitored pH and temperature conditions to obtain hydrogels with controlled bulk properties. The physical and chemical properties of the different HA-MA hydrogels were investigated via rheological studies, mechanical testing and scanning electron microscopy (SEM) imaging, which allowed us to determine the optimal biomechanical properties and develop a biocompatible scaffold. The morphological evolution processes and proliferation rates of glioblastoma cells (U251-MG) cultured on HA-MA surfaces were evaluated by comparing 2D structures with 3D structures, showing that the change in dimensionality impacted cell functions and interactions. The cell viability assays and evaluation of mitochondrial metabolism showed that the hydrogels did not interfere with cell survival. In addition, morphological studies provided evidence of cell-matrix interactions that promoted cell budding from the spheroids and the invasiveness in the surrounding environment.

Indexed as

glioblastomahyaluronic acid methacrylatehydrogeltumour microenvironment

Identifiers

PMID37888374
PMCPMC10606912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.